Therefore, we investigated the peripheral blood immunological characteristics and related variables in a group of patients with IIM, mainly containing two subgroups, anti-MDA5+ DM and ASS, to assess the risk of PF-ILD by exploring new immunological indices. This evidence concerns the gene IFIH1 and acquired idiopathic inflammatory myopathy.